Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Dofetilide is a class III antiarrhythmic agent. It is marketed under the trade name Tikosyn by Pfizer, and is available in the United States in capsules containing 125, 250, and 500 μg of dofetilide. It is not available in Europe or Australia.
Applications, Regions & Measurement
Explore the main themes, entities and connections around Dofetilide. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
cyp3a4 individuals qtc available however dose atrial fibrillation patients first qt torsades de pointes three days 500 creatinine drugs oral
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Dofetilide | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Dofetilide | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Dofetilide | ATC code | C01BD04 (WHO) | 1.00 | infobox |
| Dofetilide | Bioavailability | 96% (oral) | 1.00 | infobox |
| Dofetilide | CAS Number | 115256-11-6 Y | 1.00 | infobox |
| Dofetilide | ChEBI | CHEBI:4681 Y | 1.00 | infobox |
| Dofetilide | ChEMBL | ChEMBL473 Y | 1.00 | infobox |
| Dofetilide | ChemSpider | 64435 Y | 1.00 | infobox |
| Dofetilide | CompTox Dashboard (EPA) | DTXSID5046433 | 1.00 | infobox |
| Dofetilide | DrugBank | DB00204 Y | 1.00 | infobox |
| Dofetilide | ECHA InfoCard | 100.166.441 | 1.00 | infobox |
| Dofetilide | Elimination half-life | 10 hours | 1.00 | infobox |
| Dofetilide | Formula | C19H27N3O5S2 | 1.00 | infobox |
| Dofetilide | IUPHAR/BPS | 2604 | 1.00 | infobox |
| Dofetilide | KEGG | D00647 Y | 1.00 | infobox |
| Dofetilide | MedlinePlus | a601235 | 1.00 | infobox |
| Dofetilide | Molar mass | 441.56 g·mol−1 | 1.00 | infobox |
| Dofetilide | Protein binding | 60% -70% | 1.00 | infobox |
| Dofetilide | PubChem CID | 71329 | 1.00 | infobox |
| Dofetilide | Trade names | Tikosyn | 1.00 | infobox |
| Dofetilide | UNII | R4Z9X1N2ND | 1.00 | infobox |
| Dofetilide | causes | an increased rate of potentially life-threatening arrhythmias in comparison to other therapies | 0.90 | text |
| Dofetilide | is a | class III antiarrhythmic agent | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.